| Methods and compositions for prevention or treatment of Barth syndrome |
2022-5-10 |
2022-8-09 |
|
| Silica-based formulations of therapeutic oliogpeptides and peptidomimetics |
2022-4-07 |
2022-10-13 |
|
| Quinone-, hydroquinone- and naphthoquinone-analogues of vatiquinone for … |
2022-4-03 |
2022-6-01 |
|
| Compositions and Methods for the Treatment of Amyotrophic Lateral Sclerosis, … |
2022-3-08 |
2022-8-25 |
|
| Methods and compositions for the prevention and treatment neuropathy |
2022-3-01 |
2022-9-22 |
|
| Methods for the prevention or treatment of left ventricle remodeling |
2022-2-25 |
2022-9-22 |
|
| Methods for the prevention or treatment of no-reflow following ischemia/ … |
2021-11-08 |
2022-1-17 |
|
| Methods for performing a coronary artery bypass graft procedure |
2021-10-29 |
2022-9-08 |
|
| Methods and compositions for preventing or treating ophthalmic conditions |
2021-10-18 |
2022-1-06 |
|
| Prodrugs of mitochodria-targeting oligopeptides |
2021-6-22 |
2021-12-30 |
|
| Prodrugs of mitochodria-targeting oligopeptides |
2021-6-22 |
2021-12-30 |
|
| Methods and compositions for the treatment of muscular dystrophy |
2021-6-16 |
2021-12-23 |
|
| Analogs that target mitochondrial diseases |
2021-6-15 |
2021-8-31 |
|
| Mitochondria-targeting peptides |
2021-6-15 |
2021-8-31 |
|
| Methods and compositions for preventing or treating dominant optic atrophy |
2021-4-16 |
2021-12-30 |
|
| Crystalline salt forms of boc-d-arg-dmt-lys-(boc)-phe-nh2 |
2021-4-08 |
2021-9-23 |
|
| Crystalline dipeptides useful in the synthesis of elamipretide |
2021-4-07 |
2021-9-23 |
|
| Compositions and methods for the prevention and/or treatment of mitochondrial … |
2021-4-02 |
2022-10-20 |
|
| Processes for preparing pharmaceutically relevant peptides |
2021-3-16 |
2021-7-08 |
|
| Methods and compositions for the prevention and treatment of friedreich's … |
2020-10-30 |
2021-7-22 |
|
| COMPOSITIONS AND METHODS FOR THE PREVENTION AND/OR TREATMENT OF MITOCHONDRIAL … |
2020-10-02 |
2022-6-28 |
|
| Methods and compositions for the prevention and treatment of disease |
2020-8-17 |
2020-12-03 |
|
| Methods for the treatment of mitochondrial disease |
2020-7-15 |
2020-12-31 |
|
| Aromatic-cationic peptides and uses of same |
2020-6-17 |
2021-5-06 |
|
| Mitochondria-targeting peptides |
2020-6-11 |
2020-7-30 |
|
| Crystalline bis- and tris-hydrochloride salt of elamipretide |
2020-5-04 |
2021-3-04 |
|
| Crystalline salt forms |
2020-5-04 |
2021-2-18 |
|
| Methods of identifying and monitoring mitochondrial dysfunction using monocyte … |
2020-4-10 |
2022-6-21 |
2022-6-21 |
| Methods and compositions for preventing or treating leber's hereditary optic … |
2020-3-17 |
2021-2-11 |
|
| Aromatic-cationic peptides and uses of same |
2020-3-13 |
2021-2-11 |
|
| Methods for the prevention or treatment of vessel occlusion injury |
2020-2-28 |
2021-1-28 |
|
| Therapeutic compositions including frataxin, lactoferrin, and mitochondrial … |
2020-1-17 |
2020-10-15 |
|
| Combination therapies using cyclosporine and aromatic cationic peptides |
2020-1-14 |
2020-12-03 |
|
| Aromatic-cationic peptides and methods for using same |
2019-12-20 |
2022-8-23 |
2022-8-23 |
| Methods for reducing risks associated with heart failure and factors associated … |
2019-12-20 |
2020-11-19 |
|
| Methods and compositions for the treatment of sengers syndrome |
2019-12-05 |
2020-6-11 |
|
| Methods for the regulation of matrix metalloproteinase expression |
2019-12-02 |
2022-3-08 |
2022-3-08 |
| Neutral-cationic peptoids and uses thereof |
2019-11-15 |
2020-5-21 |
|
| Compositions and methods for the treatment of traumatic optic neuropathy |
2019-7-15 |
2021-10-28 |
|
| Methods and compositions for regulating srca2a expression levels in myocardial … |
2019-6-11 |
2020-4-16 |
|
| Methods and compositions for preventing or treating ophthalmic conditions |
2019-5-28 |
2019-6-20 |
|
| Peptide therapeutics and methods for using same |
2019-5-14 |
2019-12-12 |
|
| Methods for performing a coronary artery bypass graft procedure |
2019-4-30 |
2019-5-23 |
|
| Methods for treatment of atherosclerosis |
2019-3-08 |
2019-7-04 |
|
| Pharmaceutically relevant aromatic-cationic peptides |
2019-2-28 |
2020-1-23 |
|
| Deuterated tetrapeptides that target mitochondria |
2018-11-14 |
2020-11-19 |
|
| Peptide therapeutics and methods for using the same |
2018-11-06 |
2019-5-09 |
|
| Aromatic-cationic peptide and use of the same |
2018-9-03 |
2018-12-27 |
|
| Methods and compositions for detecting and diagnosing diseases and conditions |
2018-8-10 |
2020-1-16 |
|
| Dynamic mold shape control for direct chill casting |
2018-6-11 |
2022-5-17 |
2022-5-17 |
| Crystalline salt forms of sbt-20 |
2018-6-01 |
2018-12-06 |
|
| Aromatic-cationic peptides and uses of the same |
2018-5-24 |
2018-10-11 |
|
| Therapeutic compositions including phenazine-3-one and phenothiazine-3-one … |
2018-2-14 |
2019-1-24 |
|
| Therapeutic compositions including mitochondrial cell-penetrating peptides, … |
2018-2-13 |
2019-8-13 |
|
| Therapeutic compositions including gramicidin s peptidyl conjugates or … |
2017-12-21 |
2018-12-13 |
|
| Aromatic-cationic peptides and uses of same |
2017-11-20 |
2017-12-07 |
|
| Therapeutic compositions including triterpenoid and uses thereof to treat and … |
2017-11-01 |
2018-5-04 |
|
| N-carboxyanhydride-based-scale synthesis of elamipretide |
2017-8-09 |
2020-3-25 |
|
| Therapeutic compositions including modified creatine compounds and uses thereof … |
2017-7-18 |
2018-1-21 |
|
| Therapeutic compositions including mitochondrial-targeted creatine compounds … |
2017-7-18 |
2018-1-21 |
|
| Pharmaceutically relevant aromatic-cationic peptides |
2017-5-22 |
2017-12-22 |
|
| Compositions and methods for the prevention and treatment of mitochondrial … |
2017-5-19 |
2017-11-23 |
|
| Methods and compositions for the treatment and prevention of pulmonary arterial … |
2017-3-02 |
2017-9-08 |
|
| Methods and compositions for the prevention and treatment of duchenne muscular … |
2017-1-06 |
2017-7-13 |
|
| Therapeutic compositions including peptides and uses thereof |
2016-12-29 |
2021-7-08 |
|
| Bus detection for an autonomous vehicle |
2016-5-18 |
2017-1-31 |
2017-1-31 |
| Therapeutic compositions including phenazine-3-one and phenothiazine-3-one … |
2016-2-09 |
2016-8-13 |
|
| Therapeutic compositions including chroman derivatives and uses thereof to … |
2016-2-09 |
2016-8-13 |
|
| Therapeutic compositions comprising catechol derivatives and uses thereof to … |
2016-1-12 |
2016-7-13 |
|
| Therapeutic compositions including iron chelators and uses thereof |
2016-1-07 |
2016-7-14 |
|
| Compositions including resorufin derivatives and methods of using the same to … |
2015-12-29 |
2016-6-30 |
|
| THERAPEUTIC COMPOSITIONS INCLUDING MODULATORS OF deltaPKC AND/OR epsilonPKC, … |
2015-11-06 |
2016-9-29 |
|
| Methods for the prevention or treatment of vessel occlusion injury |
2015-7-06 |
2016-6-02 |
|
| Therapeutic compositions including galectin-3 inhibitors and uses thereof |
2015-6-30 |
2016-3-03 |
|
| Aromatic-cationic peptide formulations, compositions and methods of use |
2015-6-30 |
2016-1-07 |
|
| Therapeutic compositions including gramicidin s peptidyl conjugates or … |
2015-6-26 |
2016-12-26 |
|
| Therapeutic compositions including skq compounds and uses thereof to treat and … |
2015-6-08 |
2016-12-08 |
|
| Therapeutic compositions including bpm 31510, variants and analogues thereof, … |
2015-6-02 |
2016-12-02 |
|
| Therapeutic compositions including therapeutic small molecules and uses thereof |
2015-5-27 |
2019-6-26 |
|
| Therapeutic compositions including chromanyl compounds, variants and analogues … |
2015-5-26 |
2016-11-26 |
|
| Therapeutic compositions including acrylamido compounds or phenyl-substiituted … |
2015-3-11 |
2016-9-11 |
|
| Therapeutic compositions including mitochondrial fission inhibitor peptides, … |
2015-2-13 |
2018-2-15 |
|
| Therapeutic compositions including mitochondrial fission inhibitor peptides, … |
2015-2-13 |
2016-8-13 |
|
| Compositions and methods for treating vitiligo |
2014-12-02 |
2016-9-14 |
|
| Tetrapeptide compound and method for producing same |
2014-10-23 |
2018-5-29 |
2018-5-29 |
| Combination therapy for the treatment of ischemia-reperfusion injury |
2014-8-12 |
2016-6-23 |
|
| Aromatic-cationic peptides and uses of same |
2012-6-13 |
2015-6-10 |
|